Donald Zurbay Buys Shares of LIVN as Institutional Investors Adjust Positions
Zurbay's purchase on June 15 highlights insider interest in LIVN, amid shifting institutional investments.
Key Points
- Donald Zurbay purchased 2,383 shares of LIVN on June 15, 2026, reflecting insider interest.
- Shares of LIVN traded at $79.48, with significant activity from major institutional investors.
- Analysts from Barclays and Mizuho maintained their ratings, setting varied price targets for LIVN.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Donald Zurbay recently bought 2,383 shares of LIVN on June 15, 2026. This insider activity reflects a continued interest in the company by its internal stakeholders. At the time, LIVN shares were trading at $79.48.
Other Institutional Activity in LIVN
Several major funds have adjusted their positions in LIVN. BlackRock, Inc. reduced its holdings by 184,614 shares, bringing its total to 7,138,908 shares valued at approximately $453.7 million. Primecap Management Co. trimmed its position by 17,800 shares, ending with 4,207,052 shares worth about $267.4 million. In contrast, FMR LLC significantly increased its stake, adding 2,620,791 shares to hold 2,666,674 shares valued at $169.5 million. Meanwhile, AQR Capital Management LLC boosted its holdings by 339,230 shares, resulting in a total of 2,494,372 shares worth $154.4 million.
LivaNova PLC Stock Down 1.0%
Shares of LIVN are currently trading near $79.48. The company has seen active trading among institutional investors recently. The stock's performance and valuation metrics are closely monitored by market participants.
$LIVN stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at LivaNova PLC
On June 15, 2026, several insiders were active in LIVN's stock. Ahmet Tezel, Chief Innovation Officer, bought 2,965 shares. Francesco Bianchi purchased 2,383 shares, while Stacy Enxing Seng also acquired 2,383 shares. Donald Zurbay sold 308 shares at an average price of $79.70. Todd Schermerhorn bought 4,042 shares on the same day.
Analysts Set New Price Targets
Analysts have been reassessing their views on LIVN. On May 7, 2026, Barclays maintained a 'hold' rating with a $76.00 price target. Mizuho and Baird both maintained 'buy' ratings, with Mizuho setting a target of $90.00, and Baird aligning with Barclays at $76.00. These varied targets reflect differing outlooks on the stock's potential.
Bottom Line
The recent insider buying by Donald Zurbay and other LIVN insiders indicates confidence in the company's prospects. Institutional investors are actively adjusting their positions, reflecting varied views on LIVN's future. Analysts have maintained their ratings with differing price targets, suggesting a range of expectations for the stock's performance. As always, 13F filings and insider transactions offer a backward-looking glimpse into investor sentiment and should be considered as part of a broader investment analysis.
Get LivaNova PLC alerts
New 13F filings, insider trades, and analyst moves on $LIVN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.